NEDD4 and breast cancer: NEDD4-1 inhibits the AKT pathway and BC proliferation by mediating UPS-dependent degradation of PIP5Kα, which normally activates the PI3K/AKT pathway through PIP2 generation (Choi et al., 2016; Tran et al., 2018).